• Jon Kim Andrus, Ciro A de Quadros, Carlos Castillo Solórzano, Mirta Roses Periago, and D A Henderson.
• Pan American Health Organization, 525 23rd Street, NW, Washington, DC, USA. andrusjo@paho.org
• Vaccine. 2011 Dec 30; 29 Suppl 4: D91-6.

AbstractThe challenge for regions embarking on measles elimination will be to maintain high population immunity with excellent vaccination coverage and high-quality surveillance. Meeting this challenge will be especially critical for dealing with importations of measles virus that will occur as long as the virus is circulating anywhere in the world. Implementation of measles elimination strategies will uncover the "hidden" disease burden of rubella and congenital rubella syndrome. As was the experience in countries of Latin America and the Caribbean (LAC), integrating the elimination of measles with the elimination of rubella will greatly enhance the capacity of countries to sustain progress in the reduction of measles mortality. Countries of LAC prioritized the routine national immunization program over short-term successes. While doing so, they have also encountered new opportunities to expand the benefits of disease control and elimination activities to other aspects of public health, most importantly towards improving health care for women and newborns and reducing inequities in health in the region's poorest communities. Implementation of similar strategies could lead to the global eradication of measles, rubella, and congenital rubella syndrome early this century, while strengthening routine immunization programs, and developing the capacity to introduce new and underutilized vaccines.Copyright © 2011 Elsevier Ltd. All rights reserved.

15 keywords...

hide…